JPMorgan Chase & Co. Purchases 37,980 Shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO)
JPMorgan Chase & Co. lifted its position in shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO – Free Report) by 1,096.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,444 shares of the company’s stock after purchasing an additional 37,980 shares during the quarter. JPMorgan […]
JPMorgan Chase & Co. lifted its position in shares of Telomir Pharmaceuticals, Inc. (NASDAQ:TELO – Free Report) by 1,096.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,444 shares of the company’s stock after purchasing an additional 37,980 shares during the quarter. JPMorgan […]
